Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
The platform connects you with licensed physicians who evaluate your medical history, current medications, and weight loss goals before recommending either semaglutide or tirzepatide compounds tailored to your body's response patterns
1 Introduction Ulcerative colitis (UC) is a chronic, relapsing form of inflammatory bowel disease (IBD) characterized by immune system dysfunction and pathological overactivation of mucosal immune responses, leading to persistent inflammation and subsequent colonic mucosal injury (Raine et al., 2022)
Ongoing Support and Monitoring: Our team provides continuous guidance to help you stay on track, with regular progress check-ins and advice
The ACR Convergence 2025 data specifically showed additive benefit when GLP-1 agonists were combined with DMARDs
US$ 22.52
US$ 28.16
US$ 28.55
US$ 20.82
